TREA

88602178 - CUREVAC

Follow

Information

  • Trademark
  • 88602178
  • Serial Number
    88602178
  • Registration Number
    6318156
  • Filing Date
    September 03, 2019
    5 years ago
  • Registration Date
    April 13, 2021
    3 years ago
  • Transaction Date
    March 09, 2023
    a year ago
  • Status Date
    April 13, 2021
    3 years ago
  • Published for Opposition Date
    January 26, 2021
    3 years ago
  • Location Date
    September 30, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    TMO LAW OFFICE 112
    Employee Name
    MARTIN, LIEF ANDREW
  • Attorney Docket Number
    067249-0055
    Attorney Name
    Jennifer Fraser
    Law Office Assigned Location Code
    M30
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
CUREVAC
Case File Statements
  • DM0000: The mark consists of the stylized term "CUREVAC" with the term "CURE" appearing in orange, the term "VAC" appearing in blue, and with a blue curved line beginning at the letter "V", and extending to the right and below the wording.
  • B00001: In the statement, line 2, "Paul-Ehrlich-Str. 15" should be deleted, and "Friedrich-Miescher-Str. 15" should be inserted.
  • GS0051: Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and cancer diseases, of tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of cancers, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements, namely, dietary food supplements; Peptide carrier molecules for association with a biological macromolecule, for medical use, namely, for use in facilitating delivery of a wide range of medicinal substances; Peptidic carrier molecule for preparing a pharmaceutical composition, namely, for medical use as a protein delivery preparation to expedite or improve delivery of a therapeutic macromolecule or prophylactic biological marcomolecule; Peptide carrier molecule, sold in combination with a biological macromolecule for preparing a pharmaceutical composition, namely, for medical use as a protein delivery preparation to expedite or improve delivery of a therapeutic drug or prophylactic drug
  • PM0001: CURE VAC
  • CC0000: The color(s) orange and blue is/are claimed as a feature of the mark.
  • GS0011: Chemical reagents and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes
  • GS0441: Medical and veterinary services, in particular for therapeutic and prophylactic treatment of cancer diseases, infectious diseases, autoimmune diseases or allergies; Medical and veterinary services for treating of hereditary disorders; Medical and veterinary services for protein or enzyme supplement therapy for therapeutic or prophylactic treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases and for treatment of endocrinological or metabolic disorders
  • GS0421: Scientific and technological services and research, in particular scientific research for identification, testing and characterisation of biological macromolecules; medical testing services, namely, pre-clinical and clinical testing of macromolecules; scientific research in the nature of discovery of biological macromolecules; Laboratory services, related to custom manufacturing of pharmaceutical ingredients, for identification, testing and characterisation of biological macromolecules
Case File Event Statements
  • 3/8/2023 - a year ago
    30 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 9/30/2021 - 3 years ago
    29 - CORRECTION UNDER SECTION 7 ¿ PROCESSED Type: COC.
  • 9/30/2021 - 3 years ago
    28 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 4/30/2021 - 3 years ago
    27 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R
  • 4/13/2021 - 3 years ago
    26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/26/2021 - 3 years ago
    25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/26/2021 - 3 years ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/6/2021 - 3 years ago
    23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/17/2020 - 4 years ago
    22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/17/2020 - 4 years ago
    21 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 12/17/2020 - 4 years ago
    20 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 12/17/2020 - 4 years ago
    19 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 12/17/2020 - 4 years ago
    18 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 12/16/2020 - 4 years ago
    17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/16/2020 - 4 years ago
    16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/15/2020 - 4 years ago
    15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/30/2020 - 4 years ago
    14 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/30/2020 - 4 years ago
    13 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/30/2020 - 4 years ago
    12 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/16/2020 - 4 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/16/2020 - 4 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/15/2020 - 4 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 6/4/2020 - 4 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/9/2019 - 5 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/9/2019 - 5 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 12/9/2019 - 5 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/5/2019 - 5 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/14/2019 - 5 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM
  • 9/13/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/6/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP